These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
783 related articles for article (PubMed ID: 10607736)
1. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate. Crew TE; Elder DJ; Paraskeva C Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Elder DJ; Halton DE; Crew TE; Paraskeva C Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Elder DJ; Halton DE; Hague A; Paraskeva C Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550 [TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736 [TBL] [Abstract][Full Text] [Related]
5. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Elder DJ; Halton DE; Playle LC; Paraskeva C Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399 [TBL] [Abstract][Full Text] [Related]
6. Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells. Zhang ZH; Ouyang Q; Gan HT World J Gastroenterol; 2004 Oct; 10(20):2954-7. PubMed ID: 15378772 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912 [TBL] [Abstract][Full Text] [Related]
8. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065 [TBL] [Abstract][Full Text] [Related]
9. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664 [TBL] [Abstract][Full Text] [Related]
12. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells. Smartt HJ; Elder DJ; Hicks DJ; Williams NA; Paraskeva C Br J Cancer; 2003 Oct; 89(7):1358-65. PubMed ID: 14520472 [TBL] [Abstract][Full Text] [Related]
13. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines. Cheng J; Imanishi H; Amuro Y; Hada T Int J Cancer; 2002 Jun; 99(5):755-61. PubMed ID: 12115513 [TBL] [Abstract][Full Text] [Related]
14. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells. Meyer-Siegler K Mol Med; 2001 Dec; 7(12):850-60. PubMed ID: 11876163 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor. Moalic S; Liagre B; Le Bail JC; Beneytout JL Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300 [TBL] [Abstract][Full Text] [Related]
19. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development. Sawaoka H; Kawano S; Tsuji S; Tsujii M; Murata H; Hori M J Clin Gastroenterol; 1998; 27 Suppl 1():S47-52. PubMed ID: 9872498 [TBL] [Abstract][Full Text] [Related]
20. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]